https://archive.triblive.com/news/newsmaker-dr-herbert-zeh-iii/
Newsmaker: Dr. Herbert Zeh III
• |
The Alliance for Cancer Gene Therapy has named Dr. Herbert Zeh III, a UPMC surgical oncologist, its 2012 ACGT Investigator. Zeh is receiving a $500,000 grant with the award. That will help him continue his research into gene therapy for pancreatic cancer. His team is looking into how a modified virus can produce hormones that help combat cancer and cancer recurrence.
Noteworthy: The Alliance for Cancer Gene Therapy has named Zeh, a surgical oncologist at UPMC, its 2012 ACGT Investigator. A two-year, $500,000 grant from the alliance will support his gene-therapy research to combat pancreatic cancer.
Residence: Hampton
Age: 45
Family: Wife, Kelly; son, Ryan, 20; daughters, Makenzie, 15, and Teegan, 13
Occupation: Chief, Division of Gastrointestinal Surgical Oncology at UPMC CancerCenter; co-director, UPMC Pancreatic Cancer Center and the University of Pittsburgh Cancer Institute GI Oncology Program
Background: For six years, Zeh has co-directed the Pancreatic Cancer Center, one of the largest pancreatic cancer treatment facilities in the United States.
Education: Bachelor's degree in biology and philosophy, 1989, University of Notre Dame; doctorate in medicine, 1994, University of Pittsburgh
Quote: “Unfortunately, still in 2012, most patients who develop this disease will succumb to it. … It's the highest mountain out there.”
— Adam Smeltz
Copyright ©2026— Trib Total Media, LLC (TribLIVE.com)